“…Previously reported inhibitors include amino acid derivatives (Tamura et al, 1984;Begum et al, 1985), peptides (Ueno et al, 1987;Walker et al, 1987), tyrosine-containing synthetic 1 Abbreviations: hIR, human insulin receptor; (hlR)CHO, chínese hamster ovary cells transfected with human insulin receptor; IRTK, insulin receptor tyrosine kinase; EDAc, 1 -ethyl-3-[3-(dimethylamino)propyljcarbodiimide hydrochloride; CHO, Chinese hamster ovary; Hepes, N-(2-hydroxyethyl)piperazine-VV-2-ethananesulfomc acid; ICM, concentration of inhibitor yielding half-maximal activity; Km, Michaelis-Menten constant; Vm, maximum velocity; EGFTK, epidermal growth factor receptor tyrosine kinase. polymers (Braun et al, 1984;Sahat et al, 1988;Vicario et al, 1988a), ATP-competitive inhibitors (Davis & Czech, 1985; Kruse et al, 1988a,b), and divalent metal ions (Pang & Shafer, 1985;Vicario et al, 1988b). In addition, catecholamines (Haring et al, 1986a;Obermaier et al, 1987) and phorbol esters (Bollag et al, 1986;Haring et al, 1986b;Obermaier et al, 1987;Takayama et al, 1984) have been shown to reduce IRTK activity.…”